Published in Medicine and Law Weekly, August 25th, 2006
Completion of the transaction remains subject to satisfaction or waiver of conditions and terms of the merger agreement, European regulatory approval, and the approval of Intermagnetics' shareholders.
The merger is expected to close during the fourth quarter of calendar 2006.
Intermagnetics draws on the financial strength, operational excellence and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.